Cystic Fibrosis APIs Three-Drug Therapy
Business
- 10 month, 5 hr, 52 min ago
Sigachi Industries advances cystic fibrosis APIs with Vanzacaftor, Tezacaftor and Deutivacaftor, targeting a long-term growth opportunity in niche therapies.